Dicerna Pharmaceuticals Inc. (DRNA) Rose 5.21% or 0.47 To Price $9.5 On Tuesday


Dicerna Pharmaceuticals Inc. (DRNA) rose 5.21% or 0.47 to $9.5. It is approximately 184822 shares traded, which is 59.38% compare to the average total volume 311260. The market cap of DRNA is $198.20 million. The 52 week price range is from $2.42 to $10.24. Price of DRNA have changed 7.89% during last week. It have changed 5.74% over last month, 44.02% over last 3 months, 178.70% over last 6 months N/A

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DRNA is 7.66. It is -19.37% below current price. The 200-day Moving Averages for DRNA is 4.58. It is -51.79% below current price. The 52-week High is 10.24. It is 7.79% from the current price. The 52-week Low is 2.42. It is -74.53% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of DRNA is 1.56 on 2017-12-15. Short % to float is 2.13%. There are some statistics of DRNA. It is has market cap $198.20 million. The share outstanding is 20.86 million. The average volume is 311260. The revenue is 992000. The percent of top 15 Institution holding is 73.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DRNA is -289.17%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DRNA is -97.97%.


Tags:

Share this post